Pieralessandro Lasalvia (P Lasalvia)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Cardiovascular Events

Health Insurance

Machine Learning

Top Venues

Colombia medica (Cali, Colombia)

Human vaccines & immunotherapeutics

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Jahir Alexander Soto-Mora, Lina Maria Gómez-Espitia, Pieralessandro Lasalvia, Camilo Andrés Castellanos Moreno, Carol Andrea Casallas Vanegas, Sergio Alejandro Londoño Gutiérrez
EFFECTIVENESS AND SAFETY OF CAPLACIZUMAB IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA: HTA AND CLASSIFICATION ACCORDING TO THE METHODOLOGY ESTABLISHED IN COLOMBIA. International journal of technology assessment in health care (2023)
Norberto D Giglio, Pieralessandro Lasalvia, Manjiri Pawaskar, Cintia I Parellada, Diego Rosselli, Virginia V Babic, Silvina E Neyro
Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019. Human vaccines & immunotherapeutics 19 (2) (2023)
Norberto Giglio, Pieralessandro Lasalvia, Manjiri Pawaskar, Cintia Irene Parellada, Yaneth Gil Rojas, Paula Micone, Virginia V Babic, Silvina E Neyro
Trends in Varicella Burden of Disease Following Introduction of Routine Childhood Varicella Vaccination in Argentina: A 12-Year Time Series Analysis. Vaccines 10 (7) (2022)
Carlos Mario Olarte, Mauricio Zuluaga, Adriana Guzman, Julian Camacho, Pieralessandro Lasalvia, Nathaly Garzón-Orjuela, Laura Prieto, Carmen Elisa Nuñez, Jose Acuña, Alejandro Mejía, Maria Claudia García
Analysis of the experience of the geriatric fracture program in two institutions in Colombia: a reproducible model? Colombia medica (Cali, Colombia) 52 (3) (2021)
Pieralessandro Lasalvia, Laura Prieto, M Moreno, J Castrillón, G Romano, Nathaly Garzón-Orjuela, Diego Rosselli
International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review. Expert review of pharmacoeconomics & outcomes research 19 (4) (2019)